Loading…

Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure

We aimed to (1) investigate the relation between diuretic response (DR) with or without systemic congestion and prognosis and (2) explore the potential predictors of poor DR for risk stratification in patients with acute decompensated heart failure (ADHF). We enrolled 186 consecutive patients hospit...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2017-06, Vol.119 (12), p.2010-2016
Main Authors: Aoki, Soichiro, MD, Okumura, Takahiro, MD, PhD, Sawamura, Akinori, MD, Kitagawa, Katsuhide, MD, Morimoto, Ryota, MD, Sakakibara, Masaki, MD, PhD, Murohara, Toyoaki, MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c558t-62f5269444cb43f504ec75d6a54c2a96146316737dd8e5f0dfd785e478db8e2f3
cites cdi_FETCH-LOGICAL-c558t-62f5269444cb43f504ec75d6a54c2a96146316737dd8e5f0dfd785e478db8e2f3
container_end_page 2016
container_issue 12
container_start_page 2010
container_title The American journal of cardiology
container_volume 119
creator Aoki, Soichiro, MD
Okumura, Takahiro, MD, PhD
Sawamura, Akinori, MD
Kitagawa, Katsuhide, MD
Morimoto, Ryota, MD
Sakakibara, Masaki, MD, PhD
Murohara, Toyoaki, MD, PhD
description We aimed to (1) investigate the relation between diuretic response (DR) with or without systemic congestion and prognosis and (2) explore the potential predictors of poor DR for risk stratification in patients with acute decompensated heart failure (ADHF). We enrolled 186 consecutive patients hospitalized for ADHF. The DR was defined as (body weight at discharge − body weight at admission)/40 mg furosemide or equivalent loop diuretic dose. Systemic congestion on admission was simply evaluated by the presence of leg edema or jugular venous distention. All patients were divided into 4 groups based on the median of DR (−0.50 kg/40 mg) and the status of systemic congestion; GR/C (good DR with systemic congestion, n = 66), GR/N (good DR without systemic congestion, n = 27), PR/C (poor DR with systemic congestion, n = 48); and PR/N (poor DR without systemic congestion, n = 45). The composite outcome was defined as cardiac death and rehospitalization for worsening heart failure. In survival analysis, the cardiac event-free rate in PR/C was significantly lower than that in any other groups (log-rank, p
doi_str_mv 10.1016/j.amjcard.2017.03.030
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1891889312</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914917303545</els_id><sourcerecordid>1891889312</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-62f5269444cb43f504ec75d6a54c2a96146316737dd8e5f0dfd785e478db8e2f3</originalsourceid><addsrcrecordid>eNqFUl1rFDEUHUSxa_UnKAFffJk1mSQzyYtStq1bKLhYi48hm9yxWWeSNckU9lf5F812V4W-CIEkl3PO_Ti3ql4TPCeYtO83cz1ujI523mDSzTEtBz-pZkR0siaS0KfVDGPc1JIweVK9SGlTvoTw9nl10ghGBcXdrPp1m6CfBg8podCjfAdoEca18zq74PehK18vQ9q6rAe0CiGiczdFyM6gL5C2wSdA2lt0s0sZxhJdBP8d0gM7B7SKYJ3J6HLKhYUWpWCnDbq4B58Tch6tSqKH9zeX79CZmTKgczBh3IJPOoNFS9CxCGg3FIWX1bNeDwleHe_T6vby4utiWV9__nS1OLuuDeci123T86aVjDGzZrTnmIHpuG01Z6bRsiWspaTtaGetAN5j29tOcGCdsGsBTU9Pq3cH3W0MP6fSjxpdMjAM2kOYkiJCEiEkJU2Bvn0E3YQp-lKdIhI3TEraiYLiB5SJIaUIvdpGN-q4UwSrvaNqo46Oqr2jCtNycOG9OapP6xHsX9YfCwvg4wEAZRz3DqJKpkzUlLlHMFnZ4P6b4sMjBTM474wefsAO0r9uVGoUVjf7tdpvFekKmTNOfwMsusr4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1902499378</pqid></control><display><type>article</type><title>Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure</title><source>ScienceDirect Journals</source><creator>Aoki, Soichiro, MD ; Okumura, Takahiro, MD, PhD ; Sawamura, Akinori, MD ; Kitagawa, Katsuhide, MD ; Morimoto, Ryota, MD ; Sakakibara, Masaki, MD, PhD ; Murohara, Toyoaki, MD, PhD</creator><creatorcontrib>Aoki, Soichiro, MD ; Okumura, Takahiro, MD, PhD ; Sawamura, Akinori, MD ; Kitagawa, Katsuhide, MD ; Morimoto, Ryota, MD ; Sakakibara, Masaki, MD, PhD ; Murohara, Toyoaki, MD, PhD</creatorcontrib><description>We aimed to (1) investigate the relation between diuretic response (DR) with or without systemic congestion and prognosis and (2) explore the potential predictors of poor DR for risk stratification in patients with acute decompensated heart failure (ADHF). We enrolled 186 consecutive patients hospitalized for ADHF. The DR was defined as (body weight at discharge − body weight at admission)/40 mg furosemide or equivalent loop diuretic dose. Systemic congestion on admission was simply evaluated by the presence of leg edema or jugular venous distention. All patients were divided into 4 groups based on the median of DR (−0.50 kg/40 mg) and the status of systemic congestion; GR/C (good DR with systemic congestion, n = 66), GR/N (good DR without systemic congestion, n = 27), PR/C (poor DR with systemic congestion, n = 48); and PR/N (poor DR without systemic congestion, n = 45). The composite outcome was defined as cardiac death and rehospitalization for worsening heart failure. In survival analysis, the cardiac event-free rate in PR/C was significantly lower than that in any other groups (log-rank, p &lt;0.001), and PR/C was an independent predictor of cardiac events (hazard ratio 2.17, p = 0.016). In conclusion, the combination of in-hospital poor DR, characterized by previous ischemic heart disease, and prehospital dose of daily loop diuretics, and systemic congestion provides a risk stratification for future cardiac events in patients with ADHF.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2017.03.030</identifier><identifier>PMID: 28438307</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute Disease ; Aged ; Aged, 80 and over ; Aldosterone ; Anemia ; Angiotensin ; Antagonists ; Bioavailability ; Body weight ; Cardiology ; Cardiovascular ; Cardiovascular disease ; Congestion ; Congestive heart failure ; Continuity (mathematics) ; Coronary artery disease ; Creatinine ; Death ; Disease Progression ; Diuretics ; Dose-Response Relationship, Drug ; Drugs ; Echocardiography ; Edema ; Edema - drug therapy ; Edema - epidemiology ; Edema - etiology ; Emergencies ; Emergency medical services ; Ethics ; Etiology ; Female ; Follow-Up Studies ; Furosemide ; Geriatrics ; Glomerular filtration rate ; Guidelines ; Health hazards ; Heart failure ; Heart Failure - complications ; Heart Failure - drug therapy ; Heart Failure - epidemiology ; Heart rate ; Hemoglobin ; Humans ; Incidence ; Inhibitors ; Inpatients ; Japan - epidemiology ; Kidneys ; Lists ; Male ; Mathematical models ; Medical prognosis ; Mortality ; Multivariate analysis ; Nitrogen ; Older people ; Patients ; Pharmacokinetics ; Pharmacology ; Prognosis ; Regression analysis ; Retrospective Studies ; Risk ; Risk Assessment ; Sensitivity ; Sodium Potassium Chloride Symporter Inhibitors - administration &amp; dosage ; Statistical analysis ; Survival ; Survival analysis ; Survival Rate - trends ; Time Factors ; Treatment Outcome ; Urea ; Variance analysis</subject><ispartof>The American journal of cardiology, 2017-06, Vol.119 (12), p.2010-2016</ispartof><rights>Elsevier Inc.</rights><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Sequoia S.A. Jun 15, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-62f5269444cb43f504ec75d6a54c2a96146316737dd8e5f0dfd785e478db8e2f3</citedby><cites>FETCH-LOGICAL-c558t-62f5269444cb43f504ec75d6a54c2a96146316737dd8e5f0dfd785e478db8e2f3</cites><orcidid>0000-0001-5076-2052</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28438307$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aoki, Soichiro, MD</creatorcontrib><creatorcontrib>Okumura, Takahiro, MD, PhD</creatorcontrib><creatorcontrib>Sawamura, Akinori, MD</creatorcontrib><creatorcontrib>Kitagawa, Katsuhide, MD</creatorcontrib><creatorcontrib>Morimoto, Ryota, MD</creatorcontrib><creatorcontrib>Sakakibara, Masaki, MD, PhD</creatorcontrib><creatorcontrib>Murohara, Toyoaki, MD, PhD</creatorcontrib><title>Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>We aimed to (1) investigate the relation between diuretic response (DR) with or without systemic congestion and prognosis and (2) explore the potential predictors of poor DR for risk stratification in patients with acute decompensated heart failure (ADHF). We enrolled 186 consecutive patients hospitalized for ADHF. The DR was defined as (body weight at discharge − body weight at admission)/40 mg furosemide or equivalent loop diuretic dose. Systemic congestion on admission was simply evaluated by the presence of leg edema or jugular venous distention. All patients were divided into 4 groups based on the median of DR (−0.50 kg/40 mg) and the status of systemic congestion; GR/C (good DR with systemic congestion, n = 66), GR/N (good DR without systemic congestion, n = 27), PR/C (poor DR with systemic congestion, n = 48); and PR/N (poor DR without systemic congestion, n = 45). The composite outcome was defined as cardiac death and rehospitalization for worsening heart failure. In survival analysis, the cardiac event-free rate in PR/C was significantly lower than that in any other groups (log-rank, p &lt;0.001), and PR/C was an independent predictor of cardiac events (hazard ratio 2.17, p = 0.016). In conclusion, the combination of in-hospital poor DR, characterized by previous ischemic heart disease, and prehospital dose of daily loop diuretics, and systemic congestion provides a risk stratification for future cardiac events in patients with ADHF.</description><subject>Acute Disease</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aldosterone</subject><subject>Anemia</subject><subject>Angiotensin</subject><subject>Antagonists</subject><subject>Bioavailability</subject><subject>Body weight</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Congestion</subject><subject>Congestive heart failure</subject><subject>Continuity (mathematics)</subject><subject>Coronary artery disease</subject><subject>Creatinine</subject><subject>Death</subject><subject>Disease Progression</subject><subject>Diuretics</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drugs</subject><subject>Echocardiography</subject><subject>Edema</subject><subject>Edema - drug therapy</subject><subject>Edema - epidemiology</subject><subject>Edema - etiology</subject><subject>Emergencies</subject><subject>Emergency medical services</subject><subject>Ethics</subject><subject>Etiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Furosemide</subject><subject>Geriatrics</subject><subject>Glomerular filtration rate</subject><subject>Guidelines</subject><subject>Health hazards</subject><subject>Heart failure</subject><subject>Heart Failure - complications</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - epidemiology</subject><subject>Heart rate</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Incidence</subject><subject>Inhibitors</subject><subject>Inpatients</subject><subject>Japan - epidemiology</subject><subject>Kidneys</subject><subject>Lists</subject><subject>Male</subject><subject>Mathematical models</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Multivariate analysis</subject><subject>Nitrogen</subject><subject>Older people</subject><subject>Patients</subject><subject>Pharmacokinetics</subject><subject>Pharmacology</subject><subject>Prognosis</subject><subject>Regression analysis</subject><subject>Retrospective Studies</subject><subject>Risk</subject><subject>Risk Assessment</subject><subject>Sensitivity</subject><subject>Sodium Potassium Chloride Symporter Inhibitors - administration &amp; dosage</subject><subject>Statistical analysis</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>Survival Rate - trends</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Urea</subject><subject>Variance analysis</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFUl1rFDEUHUSxa_UnKAFffJk1mSQzyYtStq1bKLhYi48hm9yxWWeSNckU9lf5F812V4W-CIEkl3PO_Ti3ql4TPCeYtO83cz1ujI523mDSzTEtBz-pZkR0siaS0KfVDGPc1JIweVK9SGlTvoTw9nl10ghGBcXdrPp1m6CfBg8podCjfAdoEca18zq74PehK18vQ9q6rAe0CiGiczdFyM6gL5C2wSdA2lt0s0sZxhJdBP8d0gM7B7SKYJ3J6HLKhYUWpWCnDbq4B58Tch6tSqKH9zeX79CZmTKgczBh3IJPOoNFS9CxCGg3FIWX1bNeDwleHe_T6vby4utiWV9__nS1OLuuDeci123T86aVjDGzZrTnmIHpuG01Z6bRsiWspaTtaGetAN5j29tOcGCdsGsBTU9Pq3cH3W0MP6fSjxpdMjAM2kOYkiJCEiEkJU2Bvn0E3YQp-lKdIhI3TEraiYLiB5SJIaUIvdpGN-q4UwSrvaNqo46Oqr2jCtNycOG9OapP6xHsX9YfCwvg4wEAZRz3DqJKpkzUlLlHMFnZ4P6b4sMjBTM474wefsAO0r9uVGoUVjf7tdpvFekKmTNOfwMsusr4</recordid><startdate>20170615</startdate><enddate>20170615</enddate><creator>Aoki, Soichiro, MD</creator><creator>Okumura, Takahiro, MD, PhD</creator><creator>Sawamura, Akinori, MD</creator><creator>Kitagawa, Katsuhide, MD</creator><creator>Morimoto, Ryota, MD</creator><creator>Sakakibara, Masaki, MD, PhD</creator><creator>Murohara, Toyoaki, MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5076-2052</orcidid></search><sort><creationdate>20170615</creationdate><title>Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure</title><author>Aoki, Soichiro, MD ; Okumura, Takahiro, MD, PhD ; Sawamura, Akinori, MD ; Kitagawa, Katsuhide, MD ; Morimoto, Ryota, MD ; Sakakibara, Masaki, MD, PhD ; Murohara, Toyoaki, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-62f5269444cb43f504ec75d6a54c2a96146316737dd8e5f0dfd785e478db8e2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acute Disease</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aldosterone</topic><topic>Anemia</topic><topic>Angiotensin</topic><topic>Antagonists</topic><topic>Bioavailability</topic><topic>Body weight</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Congestion</topic><topic>Congestive heart failure</topic><topic>Continuity (mathematics)</topic><topic>Coronary artery disease</topic><topic>Creatinine</topic><topic>Death</topic><topic>Disease Progression</topic><topic>Diuretics</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drugs</topic><topic>Echocardiography</topic><topic>Edema</topic><topic>Edema - drug therapy</topic><topic>Edema - epidemiology</topic><topic>Edema - etiology</topic><topic>Emergencies</topic><topic>Emergency medical services</topic><topic>Ethics</topic><topic>Etiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Furosemide</topic><topic>Geriatrics</topic><topic>Glomerular filtration rate</topic><topic>Guidelines</topic><topic>Health hazards</topic><topic>Heart failure</topic><topic>Heart Failure - complications</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - epidemiology</topic><topic>Heart rate</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Incidence</topic><topic>Inhibitors</topic><topic>Inpatients</topic><topic>Japan - epidemiology</topic><topic>Kidneys</topic><topic>Lists</topic><topic>Male</topic><topic>Mathematical models</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Multivariate analysis</topic><topic>Nitrogen</topic><topic>Older people</topic><topic>Patients</topic><topic>Pharmacokinetics</topic><topic>Pharmacology</topic><topic>Prognosis</topic><topic>Regression analysis</topic><topic>Retrospective Studies</topic><topic>Risk</topic><topic>Risk Assessment</topic><topic>Sensitivity</topic><topic>Sodium Potassium Chloride Symporter Inhibitors - administration &amp; dosage</topic><topic>Statistical analysis</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>Survival Rate - trends</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Urea</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aoki, Soichiro, MD</creatorcontrib><creatorcontrib>Okumura, Takahiro, MD, PhD</creatorcontrib><creatorcontrib>Sawamura, Akinori, MD</creatorcontrib><creatorcontrib>Kitagawa, Katsuhide, MD</creatorcontrib><creatorcontrib>Morimoto, Ryota, MD</creatorcontrib><creatorcontrib>Sakakibara, Masaki, MD, PhD</creatorcontrib><creatorcontrib>Murohara, Toyoaki, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aoki, Soichiro, MD</au><au>Okumura, Takahiro, MD, PhD</au><au>Sawamura, Akinori, MD</au><au>Kitagawa, Katsuhide, MD</au><au>Morimoto, Ryota, MD</au><au>Sakakibara, Masaki, MD, PhD</au><au>Murohara, Toyoaki, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2017-06-15</date><risdate>2017</risdate><volume>119</volume><issue>12</issue><spage>2010</spage><epage>2016</epage><pages>2010-2016</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>We aimed to (1) investigate the relation between diuretic response (DR) with or without systemic congestion and prognosis and (2) explore the potential predictors of poor DR for risk stratification in patients with acute decompensated heart failure (ADHF). We enrolled 186 consecutive patients hospitalized for ADHF. The DR was defined as (body weight at discharge − body weight at admission)/40 mg furosemide or equivalent loop diuretic dose. Systemic congestion on admission was simply evaluated by the presence of leg edema or jugular venous distention. All patients were divided into 4 groups based on the median of DR (−0.50 kg/40 mg) and the status of systemic congestion; GR/C (good DR with systemic congestion, n = 66), GR/N (good DR without systemic congestion, n = 27), PR/C (poor DR with systemic congestion, n = 48); and PR/N (poor DR without systemic congestion, n = 45). The composite outcome was defined as cardiac death and rehospitalization for worsening heart failure. In survival analysis, the cardiac event-free rate in PR/C was significantly lower than that in any other groups (log-rank, p &lt;0.001), and PR/C was an independent predictor of cardiac events (hazard ratio 2.17, p = 0.016). In conclusion, the combination of in-hospital poor DR, characterized by previous ischemic heart disease, and prehospital dose of daily loop diuretics, and systemic congestion provides a risk stratification for future cardiac events in patients with ADHF.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28438307</pmid><doi>10.1016/j.amjcard.2017.03.030</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-5076-2052</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2017-06, Vol.119 (12), p.2010-2016
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_1891889312
source ScienceDirect Journals
subjects Acute Disease
Aged
Aged, 80 and over
Aldosterone
Anemia
Angiotensin
Antagonists
Bioavailability
Body weight
Cardiology
Cardiovascular
Cardiovascular disease
Congestion
Congestive heart failure
Continuity (mathematics)
Coronary artery disease
Creatinine
Death
Disease Progression
Diuretics
Dose-Response Relationship, Drug
Drugs
Echocardiography
Edema
Edema - drug therapy
Edema - epidemiology
Edema - etiology
Emergencies
Emergency medical services
Ethics
Etiology
Female
Follow-Up Studies
Furosemide
Geriatrics
Glomerular filtration rate
Guidelines
Health hazards
Heart failure
Heart Failure - complications
Heart Failure - drug therapy
Heart Failure - epidemiology
Heart rate
Hemoglobin
Humans
Incidence
Inhibitors
Inpatients
Japan - epidemiology
Kidneys
Lists
Male
Mathematical models
Medical prognosis
Mortality
Multivariate analysis
Nitrogen
Older people
Patients
Pharmacokinetics
Pharmacology
Prognosis
Regression analysis
Retrospective Studies
Risk
Risk Assessment
Sensitivity
Sodium Potassium Chloride Symporter Inhibitors - administration & dosage
Statistical analysis
Survival
Survival analysis
Survival Rate - trends
Time Factors
Treatment Outcome
Urea
Variance analysis
title Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A59%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Usefulness%20of%20the%20Combination%20of%20In-Hospital%20Poor%20Diuretic%20Response%20and%20Systemic%20Congestion%20to%20Predict%20Future%20Cardiac%20Events%20in%20Patients%20With%20Acute%20Decompensated%20Heart%20Failure&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Aoki,%20Soichiro,%20MD&rft.date=2017-06-15&rft.volume=119&rft.issue=12&rft.spage=2010&rft.epage=2016&rft.pages=2010-2016&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2017.03.030&rft_dat=%3Cproquest_cross%3E1891889312%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c558t-62f5269444cb43f504ec75d6a54c2a96146316737dd8e5f0dfd785e478db8e2f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1902499378&rft_id=info:pmid/28438307&rfr_iscdi=true